Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MaaT Pharma

MaaT Pharma
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
5 INVESTORS
Description

Provider of microbiotherapy services designed to treat serious diseases linked to imbalances in the intestinal microbiome. The company's microbiotherapy services envisages a first therapeutic application, enabling patients suffering from leukaemia and bone and joint infections get treatment to dysbiosis.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Primary Office
  • 317 Avenue Jean Jaurès
  • 69007 Lyon
  • France

+33 04 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MaaT Pharma’s full profile, request a free trial.

MaaT Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 29-Oct-2016 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Mar-2016 000.00 00.000 000.00 Completed Startup
2. Early Stage VC 24-Jul-2015 $1.11M $2.33M Completed Startup
1. Seed Round 09-Jan-2015 $1.22M $1.22M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MaaT Pharma Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SynDevRx Venture Capital-Backed Cambridge, MA 0 000.00 0000000000 0 000.00
00000 000000000000 Venture Capital-Backed Somerville, MA 00 00000 00000000000 00000
00000000 Venture Capital-Backed Paris, France 00 00000 000000000000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 0000000000 00000
00 00000000 Private Debt Financed Paris, France 00 000.00 000000000 000.00
To view this company’s complete list of competitors, request access »

MaaT Pharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BigBooster Accelerator/Incubator Minority 000 0000 000000 0
Biocodex Corporation Minority 000 0000 000000 0
CM-CIC Capital Innovation Venture Capital Minority 000 0000 000000 0
INRA Transfert Other Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0

MaaT Pharma Executive Team (6)

Name Title Board
Seat
Contact
Info
Herve Affagard Co-Founder, Board Member & Chief Executive Officer
Jean-Marc Renard Chief Business Officer
Mohamad Mohty MD Co-Founder & Medical Haematology-Oncology Advisor
Joel Dore Ph.D Co-Founder & Scientific Advisor
Pierre Rimbaud MD Co-Founder & Medical Advisor
You’re viewing 5 of 6 executives. Get the full list »

MaaT Pharma Board Members (8)

Name Representing Role Since Contact
Info
Eric de La Fortelle Ph.D Seventure Partners Board Member 000 0000
Herve Affagard MaaT Pharma Co-Founder, Board Member & Chief Executive Officer 000 0000
Isabelle de Cremoux Seventure Partners Board Member 000 0000
Jean-Marie Lefevre Biocodex Board Member 000 0000
Julien Samson Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »